We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
MT-ND1
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • MT-ND1
CANCER LIVER CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
LIHC TCGA LIHC VALIDATION PROTEIN LIHC CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Liver cancer
Human cancer
Liver hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

MT-ND1 is not prognostic in Liver Hepatocellular Carcinoma (TCGA)


Stage:


Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 4081.15
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 7538.8
Number of samples 362
Samples
Sample Description pTPM
TCGA-DD-A3A6-01A 72 years, female, white, stage:Stage II, dead, 3258 days 31370.0
TCGA-DD-A4NG-01A 77 years, male, white, stage:Stage IIIA, dead, 802 days 31313.0
TCGA-WJ-A86L-01A 68 years, female, white, stage:Stage I, alive, 345 days 28695.7
TCGA-2Y-A9H2-01A 64 years, female, white, stage:Stage I, alive, 1731 days 24458.8
TCGA-CC-A8HV-01A 51 years, female, asian, stage:Stage II, dead, 279 days 22563.1
TCGA-MR-A8JO-01A 34 years, male, white, stage:Stage I, alive, 330 days 22454.8
TCGA-NI-A8LF-01A 74 years, male, white, stage:Stage I, alive, 799 days 20838.3
TCGA-ZP-A9D4-01A 64 years, female, white, stage:'--, alive, 395 days 20819.8
TCGA-RC-A7SB-01A 53 years, male, asian, stage:Stage II, alive, 588 days 19894.4
TCGA-CC-A7IF-01A 59 years, male, asian, stage:Stage IIIA, dead, 649 days 19750.5
TCGA-WX-AA47-01A 33 years, female, white, stage:Stage IIIA, dead, 556 days 18157.6
TCGA-MI-A75C-01A 64 years, male, white, stage:Stage I, alive, 291 days 17477.8
TCGA-BC-A10R-01A 66 years, female, white, stage:'--, dead, 308 days 17081.1
TCGA-DD-AAEB-01A 60 years, male, asian, stage:Stage I, alive, 478 days 15906.9
TCGA-DD-A1EK-01A 64 years, female, white, stage:Stage IVB, dead, 558 days 15854.9
TCGA-CC-A9FS-01A 55 years, male, asian, stage:Stage II, alive, 211 days 15782.2
TCGA-DD-AAD6-01A 66 years, male, asian, stage:Stage IIIA, alive, 672 days 15662.3
TCGA-DD-AADU-01A 60 years, male, asian, stage:Stage II, alive, 554 days 15085.4
TCGA-DD-AACX-01A 66 years, male, asian, stage:Stage II, alive, 170 days 14842.9
TCGA-DD-AADL-01A 58 years, male, asian, stage:Stage I, alive, 636 days 14823.4
TCGA-WQ-A9G7-01A 71 years, female, white, stage:'--, alive, 30 days 14775.9
TCGA-CC-A5UD-01A 45 years, male, asian, stage:Stage IIIA, dead, 304 days 14666.5
TCGA-BC-A10T-01A 76 years, male, white, stage:'--, dead, 837 days 14536.8
TCGA-DD-AAD8-01A 73 years, female, asian, stage:Stage I, alive, 1219 days 14402.4
TCGA-DD-AACE-01A 62 years, male, asian, stage:Stage I, alive, 2184 days 14014.3
TCGA-LG-A9QC-01A 48 years, male, white, stage:Stage I, alive, 425 days 13896.1
TCGA-DD-A4NA-01A 67 years, female, white, stage:Stage IIIC, alive, 1008 days 13831.5
TCGA-CC-A8HT-01A 74 years, male, asian, stage:Stage IIIA, dead, 140 days 13583.4
TCGA-DD-A1EA-01A 68 years, male, asian, stage:Stage II, alive, 2415 days 13578.2
TCGA-NI-A4U2-01A 71 years, male, white, stage:Stage IIIA, dead, 1791 days 13540.5
TCGA-RC-A7SH-01A 42 years, male, asian, stage:Stage II, alive, 468 days 13455.8
TCGA-DD-A4NH-01A 65 years, female, white, stage:Stage IIIB, alive, 917 days 13433.8
TCGA-XR-A8TC-01A 43 years, female, white, stage:Stage I, alive, 1339 days 13033.6
TCGA-XR-A8TD-01A 49 years, female, white, stage:Stage IIIB, alive, 1030 days 12935.2
TCGA-ED-A82E-01A 60 years, female, asian, stage:Stage IIIA, alive, 408 days 12900.0
TCGA-DD-A4NB-01A 25 years, male, white, stage:Stage I, alive, 989 days 12822.4
TCGA-DD-A3A4-01A 37 years, male, white, stage:Stage IIIA, dead, 612 days 12726.0
TCGA-DD-AA3A-01A 81 years, female, white, stage:Stage I, dead, 410 days 12595.4
TCGA-KR-A7K8-01A 57 years, male, stage:Stage I, alive, 906 days 12584.4
TCGA-K7-A5RG-01A 66 years, male, black or african american, stage:Stage I, alive, 519 days 12412.7
TCGA-DD-A11B-01A 73 years, male, white, stage:Stage I, dead, 14 days 12337.6
TCGA-DD-A1EE-01A 73 years, male, white, stage:Stage IIIA, dead, 349 days 12209.0
TCGA-ED-A4XI-01A 58 years, male, asian, stage:Stage II, alive, 819 days 11909.3
TCGA-DD-A1EB-01A 72 years, female, stage:Stage I, alive, 2017 days 11884.8
TCGA-UB-AA0V-01A 69 years, female, white, stage:Stage I, alive, 314 days 11842.4
TCGA-CC-A7IE-01A 57 years, male, asian, stage:Stage IIIA, dead, 217 days 11782.9
TCGA-DD-AACJ-01A 75 years, male, asian, stage:Stage II, alive, 2102 days 11769.2
TCGA-DD-AAEK-01A 51 years, male, asian, stage:Stage II, alive, 1067 days 11732.3
TCGA-2Y-A9HA-01A 70 years, male, white, stage:Stage II, dead, 36 days 11691.3
TCGA-ED-A7PY-01A 20 years, female, asian, stage:Stage II, alive, 390 days 11668.3
TCGA-G3-AAV4-01A 83 years, female, white, stage:Stage I, dead, 27 days 11555.7
TCGA-CC-A5UC-01A 63 years, male, asian, stage:Stage IIIA, dead, 347 days 11420.0
TCGA-BC-A112-01A 80 years, male, white, stage:'--, dead, 153 days 11392.4
TCGA-DD-AACA-01A 65 years, male, asian, stage:Stage I, alive, 2301 days 11358.1
TCGA-2Y-A9H0-01A 49 years, male, white, stage:Stage IIIA, alive, 3675 days 11311.2
TCGA-2Y-A9GW-01A 64 years, male, white, stage:Stage I, dead, 1271 days 11258.5
TCGA-DD-A11C-01A 69 years, male, white, stage:Stage I, alive, 662 days 11220.6
TCGA-2Y-A9GZ-01A 82 years, female, white, stage:Stage II, dead, 848 days 11216.6
TCGA-KR-A7K0-01A 65 years, male, white, stage:Stage I, dead, 65 days 11183.2
TCGA-G3-AAV1-01A 51 years, male, asian, stage:Stage IIIC, dead, 359 days 11164.4
TCGA-K7-AAU7-01A 61 years, male, white, stage:Stage II, alive, 359 days 11119.0
TCGA-WX-AA46-01A 61 years, male, white, stage:Stage II, alive, 756 days 11051.6
TCGA-CC-A7IL-01A 61 years, male, asian, stage:Stage IIIA, dead, 278 days 11042.0
TCGA-DD-AACQ-01A 50 years, male, asian, stage:Stage II, dead, 432 days 11006.6
TCGA-DD-A4ND-01A 56 years, female, white, stage:Stage I, alive, 2746 days 10979.7
TCGA-CC-A8HS-01A 18 years, male, asian, stage:Stage IIIC, dead, 300 days 10958.8
TCGA-G3-A3CH-01A 53 years, male, asian, stage:Stage IIIA, alive, 780 days 10950.0
TCGA-MR-A520-01A 58 years, male, white, stage:Stage I, alive, 229 days 10933.1
TCGA-RC-A7SF-01A 66 years, male, asian, stage:Stage I, alive, 579 days 10786.0
TCGA-DD-A115-01A 53 years, male, white, stage:Stage IIIA, dead, 2542 days 10720.9
TCGA-DD-AADR-01A 58 years, male, asian, stage:Stage I, alive, 2028 days 10581.9
TCGA-DD-A119-01A 40 years, male, asian, stage:Stage IV, dead, 223 days 10552.9
TCGA-G3-A7M8-01A 31 years, male, asian, stage:Stage I, alive, 430 days 10466.3
TCGA-DD-A4NQ-01A 60 years, male, white, stage:Stage II, dead, 373 days 10448.9
TCGA-BC-A8YO-01A 66 years, female, white, stage:Stage IIIC, alive, 562 days 10411.3
TCGA-4R-AA8I-01A 66 years, male, white, stage:Stage II, dead, 262 days 10388.4
TCGA-DD-AAD0-01A 73 years, female, asian, stage:Stage I, alive, 137 days 10305.8
TCGA-ED-A7PX-01A 48 years, female, asian, stage:Stage II, alive, 6 days 10265.1
TCGA-ED-A97K-01A 54 years, male, asian, stage:Stage IIIA, alive, 6 days 10261.2
TCGA-DD-AADG-01A 70 years, male, asian, stage:Stage IIIA, alive, 1145 days 10256.8
TCGA-DD-AADC-01A 53 years, male, asian, stage:Stage I, dead, 425 days 10221.0
TCGA-2Y-A9GV-01A 54 years, female, white, stage:Stage I, dead, 2532 days 10202.4
TCGA-2Y-A9H6-01A 68 years, female, white, stage:Stage I, alive, 357 days 10187.2
TCGA-BC-A110-01A 51 years, female, black or african american, stage:'--, dead, 2116 days 10145.9
TCGA-DD-AAE9-01A 69 years, male, asian, stage:Stage I, alive, 722 days 10111.9
TCGA-DD-AACV-01A 53 years, male, asian, stage:Stage I, alive, 1531 days 10023.4
TCGA-DD-AAEA-01A 65 years, male, asian, stage:Stage I, alive, 575 days 10017.3
TCGA-DD-A4NS-01A 61 years, female, white, stage:Stage I, dead, 2456 days 10011.4
TCGA-G3-A5SL-01A 70 years, male, white, stage:Stage II, alive, 621 days 10009.6
TCGA-DD-AAE1-01A 52 years, male, asian, stage:Stage I, alive, 552 days 9975.8
TCGA-DD-AADW-01A 48 years, male, asian, stage:Stage I, alive, 587 days 9952.7
TCGA-5R-AAAM-01A 65 years, female, white, stage:Stage II, dead, 46 days 9944.8
TCGA-BC-A3KF-01A 66 years, female, white, stage:Stage I, alive, 8 days 9901.3
TCGA-DD-A116-01A 68 years, male, asian, stage:Stage IIIA, dead, 1622 days 9863.8
TCGA-DD-AAE6-01A 59 years, female, asian, stage:Stage I, alive, 141 days 9676.7
TCGA-G3-A5SK-01A 58 years, male, white, stage:Stage I, alive, 744 days 9675.5
TCGA-DD-AADK-01A 68 years, female, asian, stage:Stage II, alive, 1049 days 9621.6
TCGA-ZS-A9CF-01A 64 years, male, white, stage:Stage II, alive, 2412 days 9579.5
TCGA-BC-A10X-01A 52 years, female, white, stage:Stage IIIA, dead, 770 days 9539.0
TCGA-FV-A3R3-01A 38 years, female, white, stage:Stage I, dead, 366 days 9526.3
TCGA-UB-AA0U-01A 60 years, male, white, stage:Stage II, alive, 327 days 9512.5
TCGA-CC-A3MC-01A 54 years, male, asian, stage:Stage IIIA, alive, 363 days 9417.5
TCGA-DD-AAVR-01A 44 years, male, asian, stage:Stage I, alive, 2513 days 9364.0
TCGA-DD-A3A8-01A 75 years, male, white, stage:Stage II, dead, 11 days 9278.8
TCGA-BC-A216-01A 62 years, female, white, stage:Stage IIIA, alive, 1351 days 9238.7
TCGA-DD-AAVW-01A 35 years, male, asian, stage:Stage I, alive, 2317 days 9236.5
TCGA-CC-A3MA-01A 61 years, male, asian, stage:Stage IIIA, dead, 303 days 9223.2
TCGA-HP-A5MZ-01A 78 years, male, stage:Stage I, dead, 91 days 9128.8
TCGA-DD-A1EF-01A 57 years, female, white, stage:Stage I, dead, 394 days 9122.4
TCGA-BC-A10Z-01A 62 years, female, white, stage:Stage I, dead, 34 days 9110.6
TCGA-DD-A73D-01A 68 years, female, white, stage:Stage II, alive, 693 days 9076.3
TCGA-DD-AAVY-01A 56 years, male, asian, stage:Stage IIIA, alive, 1970 days 9060.2
TCGA-5R-AA1D-01A 17 years, female, white, stage:Stage IIIA, alive, 449 days 8986.5
TCGA-G3-A6UC-01A 65 years, male, white, stage:Stage IIIB, alive, 671 days 8935.0
TCGA-LG-A9QD-01A 68 years, male, white, stage:Stage IIIA, alive, 366 days 8928.8
TCGA-2Y-A9H8-01A 85 years, female, white, stage:'--, dead, 633 days 8906.0
TCGA-DD-AAEH-01A 73 years, male, asian, stage:Stage I, alive, 784 days 8903.8
TCGA-ED-A8O6-01A 50 years, female, asian, stage:Stage IIIA, dead, 56 days 8795.4
TCGA-DD-A4NJ-01A 54 years, female, white, stage:Stage II, alive, 928 days 8688.7
TCGA-FV-A496-01A 84 years, female, white, stage:Stage I, alive, 10 days 8683.3
TCGA-G3-A3CI-01A 71 years, male, white, stage:Stage I, alive, 180 days 8677.3
TCGA-CC-A7IK-01A 59 years, male, asian, stage:Stage IIIA, dead, 262 days 8664.0
TCGA-G3-A25U-01A 63 years, female, asian, stage:Stage I, alive, 1636 days 8564.3
TCGA-ED-A66X-01A 35 years, male, asian, stage:Stage IIIA, alive, 406 days 8516.0
TCGA-RC-A6M4-01A 74 years, female, white, stage:Stage IIIA, alive, 22 days 8502.4
TCGA-DD-A4NF-01A 72 years, male, white, stage:Stage I, alive, 942 days 8475.7
TCGA-RC-A6M5-01A 20 years, female, white, stage:Stage IVA, alive, 15 days 8444.7
TCGA-EP-A3JL-01A 76 years, male, white, stage:Stage I, alive, 303 days 8401.4
TCGA-BD-A3ER-01A 62 years, male, white, stage:Stage II, alive, 1115 days 8389.3
TCGA-XR-A8TF-01A 74 years, male, white, stage:Stage I, dead, 693 days 8374.1
TCGA-DD-AADB-01A 51 years, male, asian, stage:Stage I, alive, 1242 days 8358.1
TCGA-DD-A4NE-01A 75 years, female, white, stage:Stage IIIA, dead, 660 days 8344.4
TCGA-BC-A10S-01A 81 years, male, white, stage:'--, dead, 1423 days 8198.8
TCGA-DD-AACS-01A 39 years, male, asian, stage:Stage I, alive, 1804 days 8129.8
TCGA-DD-A4NL-01A 46 years, male, white, stage:Stage I, alive, 1711 days 8126.4
TCGA-DD-AAD1-01A 51 years, female, asian, stage:Stage I, alive, 564 days 8113.4
TCGA-DD-AAW3-01A 69 years, male, asian, stage:Stage I, alive, 1633 days 8111.6
TCGA-DD-AAED-01A 51 years, male, asian, stage:Stage I, alive, 763 days 8016.1
TCGA-DD-AACT-01A 69 years, female, asian, stage:Stage I, alive, 1562 days 7988.7
TCGA-BC-A5W4-01A 69 years, male, white, stage:Stage IIIA, dead, 547 days 7988.4
TCGA-DD-AADV-01A 50 years, male, asian, stage:Stage I, alive, 574 days 7946.4
TCGA-DD-A1EH-01A 23 years, male, white, stage:Stage III, alive, 1495 days 7925.1
TCGA-DD-A4NK-01A 80 years, female, white, stage:Stage IIIA, dead, 1210 days 7878.2
TCGA-BC-A3KG-01A 68 years, female, white, stage:Stage II, alive, 680 days 7809.1
TCGA-5C-A9VH-01A 70 years, male, white, stage:Stage I, alive, 322 days 7791.1
TCGA-DD-AADF-01A 64 years, female, asian, stage:Stage I, dead, 115 days 7754.8
TCGA-CC-A9FW-01A 68 years, male, asian, stage:Stage IIIA, alive, 248 days 7707.5
TCGA-DD-AADD-01A 51 years, male, asian, stage:Stage I, alive, 1231 days 7612.9
TCGA-DD-A3A7-01A 67 years, male, stage:Stage IIIB, dead, 419 days 7575.6
TCGA-DD-A39W-01A 29 years, female, white, stage:Stage III, dead, 827 days 7515.9
TCGA-BC-A10U-01A 69 years, male, white, stage:'--, dead, 837 days 7505.1
TCGA-DD-AAW2-01A 69 years, male, asian, stage:Stage I, alive, 1855 days 7462.9
TCGA-2Y-A9GX-01A 68 years, male, white, stage:Stage I, alive, 2442 days 7406.8
TCGA-ZP-A9D1-01A 56 years, female, white, stage:'--, alive, 21 days 7384.5
TCGA-2Y-A9GU-01A 55 years, female, white, stage:Stage I, alive, 1939 days 7373.2
TCGA-DD-A118-01A 77 years, female, white, stage:Stage II, alive, 3437 days 7310.7
TCGA-DD-AAEI-01A 72 years, male, asian, stage:Stage I, alive, 1531 days 7304.5
TCGA-DD-AAVQ-01A 38 years, male, asian, stage:Stage I, alive, 2728 days 7298.6
TCGA-ZP-A9CV-01A 59 years, male, white, stage:'--, dead, 1088 days 7294.0
TCGA-DD-A3A2-01A 76 years, female, white, stage:Stage I, dead, 2131 days 7268.2
TCGA-DD-A1EI-01A 46 years, male, asian, stage:Stage I, alive, 183 days 7247.3
TCGA-DD-AACL-01A 66 years, female, asian, stage:Stage I, dead, 107 days 7205.5
TCGA-DD-A73A-01A 71 years, male, white, stage:Stage I, alive, 728 days 7186.8
TCGA-EP-A26S-01A 70 years, male, white, stage:Stage I, alive, 608 days 7146.8
TCGA-DD-AAVS-01A 56 years, male, asian, stage:Stage I, alive, 1823 days 7041.6
TCGA-WQ-AB4B-01A 62 years, male, white, stage:Stage II, alive, 395 days 7019.7
TCGA-FV-A23B-01A 70 years, female, white, stage:Stage II, dead, 1852 days 6941.7
TCGA-CC-A1HT-01A 50 years, male, asian, stage:Stage IIIA, dead, 101 days 6912.6
TCGA-DD-A4NO-01A 65 years, male, white, stage:Stage I, alive, 2245 days 6902.5
TCGA-DD-AAVX-01A 38 years, male, asian, stage:Stage II, alive, 1718 days 6891.6
TCGA-DD-A3A3-01A 45 years, male, asian, stage:Stage I, dead, 535 days 6821.3
TCGA-WX-AA44-01A 64 years, female, white, stage:Stage I, alive, 615 days 6696.3
TCGA-DD-A4NP-01A 32 years, male, white, stage:Stage I, alive, 3308 days 6696.3
TCGA-DD-A1EC-01A 20 years, female, white, stage:Stage I, alive, 602 days 6671.5
TCGA-ZS-A9CE-01A 79 years, female, white, stage:Stage II, alive, 1241 days 6633.8
TCGA-QA-A7B7-01A 48 years, male, black or african american, stage:Stage II, alive, 94 days 6606.6
TCGA-DD-A1EL-01A 23 years, male, black or african american, stage:Stage II, dead, 415 days 6606.5
TCGA-GJ-A3OU-01A 59 years, male, white, stage:Stage I, alive, 879 days 6602.5
TCGA-DD-AAEG-01A 59 years, female, asian, stage:Stage I, alive, 719 days 6537.2
TCGA-DD-A4NN-01A 56 years, female, white, stage:Stage I, dead, 899 days 6530.0
TCGA-G3-A7M9-01A 70 years, male, white, stage:Stage IIIB, dead, 56 days 6510.1
TCGA-RG-A7D4-01A 69 years, male, black or african american, stage:Stage II, alive, 1098 days 6502.2
TCGA-KR-A7K2-01A 64 years, male, white, stage:Stage I, alive, 829 days 6453.8
TCGA-DD-AAVZ-01A 38 years, male, asian, stage:Stage I, alive, 1900 days 6427.6
TCGA-DD-AACY-01A 61 years, male, asian, stage:Stage I, alive, 1450 days 6419.5
TCGA-2Y-A9H4-01A 68 years, male, black or african american, stage:Stage I, alive, 1452 days 6406.8
TCGA-5R-AA1C-01A 57 years, male, white, stage:Stage II, alive, 520 days 6353.9
TCGA-DD-AAE2-01A 51 years, male, asian, stage:Stage I, alive, 638 days 6340.8
TCGA-RC-A7SK-01A 59 years, male, asian, stage:Stage I, alive, 472 days 6316.0
TCGA-2Y-A9GS-01A 58 years, male, white, stage:'--, dead, 724 days 6259.2
TCGA-G3-A25Z-01A 58 years, male, asian, stage:Stage I, alive, 655 days 6230.6
TCGA-DD-AADJ-01A 70 years, female, asian, stage:Stage I, alive, 1066 days 6220.2
TCGA-DD-A114-01A 42 years, male, black or african american, stage:Stage II, dead, 1149 days 6195.6
TCGA-MI-A75H-01A 77 years, male, white, stage:'--, alive, 747 days 6163.3
TCGA-DD-A1ED-01A 68 years, male, white, stage:Stage I, alive, 2301 days 6132.3
TCGA-DD-AACU-01A 59 years, male, asian, stage:Stage I, alive, 1567 days 6103.1
TCGA-DD-AAEE-01A 55 years, male, asian, stage:Stage I, alive, 810 days 6050.0
TCGA-ED-A7XO-01A 29 years, male, asian, stage:Stage IIIA, alive, 427 days 6044.0
TCGA-DD-AAW0-01A 54 years, male, asian, stage:Stage I, alive, 2015 days 6009.4
TCGA-CC-A7IG-01A 47 years, male, asian, stage:Stage II, dead, 299 days 5990.4
TCGA-DD-A73F-01A 77 years, female, white, stage:Stage I, alive, 1085 days 5974.4
TCGA-ED-A7PZ-01A 61 years, male, asian, stage:Stage II, alive, 6 days 5904.8
TCGA-DD-AAD2-01A 66 years, male, asian, stage:Stage I, alive, 658 days 5902.5
TCGA-DD-A113-01A 55 years, female, white, stage:Stage II, alive, 2425 days 5874.3
TCGA-G3-AAV2-01A 50 years, male, white, stage:Stage I, alive, 372 days 5859.5
TCGA-DD-AADA-01A 66 years, female, asian, stage:Stage I, alive, 1233 days 5850.8
TCGA-ZP-A9CY-01A 66 years, female, white, stage:'--, alive, 782 days 5848.1
TCGA-DD-A73B-01A 72 years, female, white, stage:Stage I, dead, 283 days 5843.4
TCGA-EP-A2KC-01A 62 years, male, black or african american, stage:Stage I, dead, 19 days 5779.7
TCGA-DD-AAW1-01A 55 years, male, asian, stage:Stage IIIA, alive, 1989 days 5775.2
TCGA-G3-A7M7-01A 65 years, male, white, stage:Stage I, alive, 361 days 5773.0
TCGA-G3-A7M6-01A 60 years, female, white, stage:Stage I, alive, 632 days 5751.1
TCGA-2Y-A9H9-01A 70 years, male, white, stage:Stage I, alive, 697 days 5701.9
TCGA-BD-A3EP-01A 75 years, female, black or african american, stage:Stage I, alive, 409 days 5689.6
TCGA-DD-A3A9-01A 64 years, female, white, stage:Stage IVB, dead, 931 days 5612.7
TCGA-DD-AADP-01A 45 years, male, asian, stage:Stage I, alive, 458 days 5589.4
TCGA-ZS-A9CD-01A 73 years, male, white, stage:Stage II, dead, 1386 days 5548.2
TCGA-2Y-A9HB-01A 66 years, male, stage:Stage I, alive, 260 days 5525.2
TCGA-G3-A7M5-01A 76 years, male, asian, stage:Stage I, alive, 447 days 5490.6
TCGA-2Y-A9H5-01A 59 years, female, white, stage:Stage I, dead, 555 days 5486.8
TCGA-DD-AAE3-01A 50 years, male, asian, stage:Stage I, alive, 566 days 5485.2
TCGA-2Y-A9H7-01A 81 years, female, white, stage:Stage I, alive, 1168 days 5480.1
TCGA-ED-A66Y-01A 51 years, female, asian, stage:Stage IIIA, dead, 296 days 5479.7
TCGA-EP-A12J-01A 62 years, male, black or african american, stage:Stage I, alive, 570 days 5429.7
TCGA-RC-A7S9-01A 47 years, female, asian, stage:Stage I, alive, 640 days 5421.2
TCGA-G3-A5SJ-01A 59 years, male, white, stage:Stage I, alive, 698 days 5411.8
TCGA-ZP-A9D0-01A 67 years, female, black or african american, stage:'--, alive, 1091 days 5388.7
TCGA-DD-A3A5-01A 66 years, female, white, stage:Stage III, dead, 3125 days 5325.6
TCGA-MI-A75E-01A 61 years, male, white, stage:Stage IIIC, alive, 507 days 5209.8
TCGA-DD-AACK-01A 70 years, male, asian, stage:Stage I, alive, 9 days 5196.9
TCGA-ZP-A9D2-01A 51 years, male, white, stage:'--, dead, 765 days 5180.5
TCGA-CC-5263-01A 35 years, male, asian, stage:Stage IIIA, dead, 129 days 5116.9
TCGA-G3-A25V-01A 68 years, male, white, stage:Stage I, alive, 860 days 5116.4
TCGA-GJ-A6C0-01A 75 years, female, white, stage:Stage II, dead, 31 days 5102.8
TCGA-G3-A5SM-01A 58 years, male, white, stage:Stage II, alive, 520 days 5070.9
TCGA-DD-AACZ-01A 63 years, female, asian, stage:Stage I, dead, 171 days 5050.1
TCGA-ED-A7XP-01A 53 years, female, asian, stage:Stage II, alive, 400 days 5037.2
TCGA-DD-AAC9-01A 51 years, male, asian, stage:Stage I, alive, 347 days 5012.5
TCGA-K7-A5RF-01A 64 years, male, white, stage:Stage I, alive, 631 days 5005.5
TCGA-ZS-A9CG-01A 55 years, male, white, stage:Stage II, alive, 341 days 5000.1
TCGA-ED-A627-01A 74 years, male, white, stage:Stage I, alive, 423 days 4995.9
TCGA-G3-A25S-01A 64 years, male, white, stage:Stage I, dead, 416 days 4963.2
TCGA-CC-A7IH-01A 58 years, male, asian, stage:Stage IIIA, alive, 365 days 4957.4
TCGA-UB-A7MD-01A 67 years, male, black or african american, stage:Stage I, dead, 52 days 4951.3
TCGA-DD-A39Z-01A 43 years, female, stage:Stage II, dead, 601 days 4950.7
TCGA-2Y-A9GT-01A 51 years, male, white, stage:Stage I, dead, 1624 days 4940.0
TCGA-KR-A7K7-01A 61 years, female, white, stage:Stage II, alive, 951 days 4936.2
TCGA-ED-A459-01A 47 years, male, asian, stage:Stage II, alive, 910 days 4924.8
TCGA-DD-A4NR-01A 85 years, female, white, stage:Stage I, dead, 9 days 4905.8
TCGA-DD-AAE0-01A 45 years, female, asian, stage:Stage IIIA, alive, 555 days 4904.3
TCGA-DD-A73E-01A 66 years, male, white, stage:Stage I, alive, 44 days 4852.0
TCGA-DD-AADQ-01A 59 years, male, asian, stage:Stage II, alive, 436 days 4812.5
TCGA-O8-A75V-01A 54 years, male, stage:Stage I, alive, 538 days 4807.3
TCGA-FV-A3I1-01A 81 years, female, white, stage:Stage II, dead, 247 days 4774.9
TCGA-XR-A8TG-01A 58 years, male, white, stage:Stage I, alive, 898 days 4771.3
TCGA-PD-A5DF-01A 58 years, female, white, stage:Stage IIIB, dead, 639 days 4764.8
TCGA-BC-A69I-01A 69 years, male, white, stage:Stage I, alive, 387 days 4683.1
TCGA-5C-AAPD-01A 61 years, male, asian, stage:Stage II, alive, 20 days 4628.6
TCGA-DD-AAVU-01A 46 years, male, asian, stage:Stage II, alive, 2202 days 4601.9
TCGA-G3-AAV7-01A 38 years, male, asian, stage:Stage II, alive, 361 days 4581.9
TCGA-BD-A2L6-01A 69 years, male, white, stage:'--, alive, 1363 days 4561.5
TCGA-DD-AADY-01A 55 years, female, asian, stage:Stage I, alive, 555 days 4561.0
TCGA-CC-5264-01A 71 years, male, asian, stage:Stage IIIA, dead, 102 days 4559.8
TCGA-UB-A7MC-01A 59 years, male, white, stage:Stage IIIA, alive, 500 days 4549.2
TCGA-EP-A3RK-01A 73 years, male, white, stage:Stage IIIA, alive, 363 days 4514.3
TCGA-DD-AACC-01A 61 years, male, asian, stage:Stage I, dead, 1685 days 4512.3
TCGA-DD-AACW-01A 43 years, male, asian, stage:Stage I, alive, 1424 days 4504.8
TCGA-ZP-A9CZ-01A 72 years, male, asian, stage:'--, alive, 706 days 4501.9
TCGA-ED-A8O5-01A 59 years, female, asian, stage:Stage IIIA, alive, 406 days 4493.3
TCGA-UB-A7ME-01A 51 years, male, asian, stage:Stage I, alive, 486 days 4490.4
TCGA-T1-A6J8-01A 68 years, male, white, stage:'--, alive, 23 days 4476.1
TCGA-XR-A8TE-01A 16 years, male, white, stage:Stage IIIA, alive, 925 days 4470.5
TCGA-CC-5259-01A 60 years, female, asian, stage:Stage IIIC, alive, 250 days 4406.7
TCGA-DD-AAE4-01A 49 years, female, asian, stage:Stage I, alive, 608 days 4397.7
TCGA-FV-A2QR-01A 75 years, male, white, stage:Stage I, dead, 581 days 4381.2
TCGA-G3-A25Y-01A 52 years, female, asian, stage:Stage I, dead, 452 days 4365.1
TCGA-G3-AAUZ-01A 48 years, male, stage:Stage I, alive, 480 days 4342.3
TCGA-DD-AACP-01A 64 years, male, asian, stage:Stage I, alive, 415 days 4331.1
TCGA-HP-A5N0-01A 90 years, female, stage:'--, dead, 752 days 4300.6
TCGA-CC-A3MB-01A 36 years, male, asian, stage:Stage IIIA, dead, 315 days 4239.0
TCGA-DD-AAD5-01A 54 years, male, asian, stage:Stage I, alive, 1345 days 4216.3
TCGA-DD-A1EG-01A 76 years, male, white, stage:Stage I, dead, 1372 days 4183.5
TCGA-CC-5262-01A 67 years, male, asian, stage:Stage IIIC, dead, 103 days 4170.9
TCGA-2Y-A9H3-01A 45 years, male, white, stage:Stage II, alive, 1516 days 4169.3
TCGA-G3-AAV5-01A 67 years, male, white, stage:Stage II, alive, 354 days 4148.4
TCGA-DD-AAVV-01A 56 years, male, asian, stage:Stage II, alive, 2455 days 4147.4
TCGA-DD-AAVP-01A 48 years, male, asian, stage:Stage I, alive, 2752 days 4131.3
TCGA-G3-AAV0-01A 58 years, male, asian, stage:Stage I, alive, 476 days 4096.2
TCGA-BC-A10Q-01A 72 years, female, white, stage:'--, dead, 1135 days 4066.1
TCGA-DD-AACF-01A 68 years, male, asian, stage:Stage I, dead, 365 days 3949.1
TCGA-DD-AACN-01A 32 years, male, asian, stage:Stage I, alive, 1302 days 3944.4
TCGA-FV-A3R2-01A 75 years, male, white, stage:Stage I, dead, 194 days 3941.9
TCGA-BC-A10Y-01A 76 years, male, white, stage:'--, dead, 711 days 3898.2
TCGA-CC-A8HU-01A 39 years, female, asian, stage:Stage IIIA, dead, 344 days 3887.3
TCGA-BW-A5NO-01A 50 years, male, black or african american, stage:Stage IIIA, alive, 20 days 3858.7
TCGA-UB-A7MB-01A 24 years, male, white, stage:Stage II, alive, 601 days 3842.1
TCGA-CC-5258-01A 48 years, male, asian, stage:Stage II, dead, 129 days 3825.9
TCGA-EP-A2KB-01A 46 years, female, white, stage:Stage I, dead, 596 days 3729.1
TCGA-DD-A4NI-01A 67 years, male, white, stage:Stage II, alive, 816 days 3714.4
TCGA-CC-5260-01A 61 years, female, asian, stage:Stage IIIC, dead, 87 days 3690.1
TCGA-DD-AACD-01A 48 years, male, asian, stage:Stage I, dead, 381 days 3667.0
TCGA-FV-A2QQ-01A 80 years, male, white, stage:Stage I, alive, 729 days 3648.5
TCGA-G3-AAV3-01A 58 years, female, white, stage:Stage II, alive, 412 days 3643.7
TCGA-2Y-A9GY-01A 64 years, female, white, stage:Stage II, dead, 757 days 3590.0
TCGA-G3-A5SI-01A 44 years, male, asian, stage:Stage II, dead, 768 days 3587.1
TCGA-G3-A3CK-01A 61 years, male, asian, stage:Stage I, alive, 585 days 3569.3
TCGA-DD-AACH-01A 69 years, male, asian, stage:Stage II, dead, 195 days 3560.1
TCGA-FV-A3I0-01A 76 years, female, white, stage:Stage II, alive, 848 days 3542.0
TCGA-DD-A11D-01A 57 years, female, white, stage:Stage I, dead, 1560 days 3541.6
TCGA-DD-AAC8-01A 72 years, male, asian, stage:Stage I, dead, 16 days 3533.1
TCGA-DD-AACB-01A 74 years, female, asian, stage:Stage I, alive, 2324 days 3521.3
TCGA-MI-A75G-01A 63 years, male, white, stage:Stage II, alive, 698 days 3519.6
TCGA-5C-A9VG-01A 58 years, male, white, stage:Stage II, alive, 328 days 3499.3
TCGA-DD-AAE7-01A 72 years, male, asian, stage:Stage I, alive, 644 days 3473.8
TCGA-DD-AACO-01A 40 years, male, asian, stage:Stage I, alive, 1876 days 3413.2
TCGA-LG-A6GG-01A 79 years, female, white, stage:Stage II, alive, 387 days 3408.8
TCGA-DD-AAD3-01A 43 years, male, asian, stage:Stage I, alive, 1295 days 3325.3
TCGA-DD-A4NV-01A 61 years, male, white, stage:Stage IIIA, alive, 2398 days 3307.8
TCGA-G3-A3CG-01A 80 years, male, white, stage:Stage I, alive, 673 days 3291.7
TCGA-RC-A6M6-01A 75 years, male, white, stage:Stage II, alive, 9 days 3188.8
TCGA-DD-A3A1-01A 65 years, male, stage:Stage IIIA, dead, 233 days 3128.5
TCGA-2Y-A9H1-01A 58 years, male, white, stage:Stage I, dead, 1229 days 3116.8
TCGA-CC-5261-01A 44 years, male, asian, stage:Stage II, dead, 97 days 3100.5
TCGA-UB-A7MF-01A 56 years, male, white, stage:Stage IIIA, dead, 214 days 3018.8
TCGA-YA-A8S7-01A 68 years, male, white, stage:Stage IIIA, dead, 412 days 3018.2
TCGA-ES-A2HS-01A 80 years, male, white, stage:Stage I, dead, 688 days 2992.9
TCGA-G3-A25T-01A 45 years, female, white, stage:Stage IIIA, alive, 1553 days 2924.3
TCGA-CC-A3M9-01A 45 years, male, asian, stage:Stage IIIA, dead, 300 days 2885.0
TCGA-DD-AADI-01A 43 years, female, asian, stage:Stage I, alive, 1085 days 2842.8
TCGA-G3-AAV6-01A 53 years, female, white, stage:Stage IIIA, dead, 65 days 2795.5
TCGA-G3-A3CJ-01A 52 years, male, american indian or alaska native, stage:Stage II, alive, 594 days 2789.7
TCGA-DD-A73C-01A 65 years, female, white, stage:Stage IIIA, alive, 701 days 2773.0
TCGA-DD-AACG-01A 52 years, male, asian, stage:Stage II, dead, 469 days 2767.2
TCGA-GJ-A9DB-01A 68 years, male, white, stage:Stage I, dead, 67 days 2677.0
TCGA-DD-A1EJ-01A 71 years, female, white, stage:Stage IIIC, dead, 1005 days 2658.9
TCGA-UB-A7MA-01A 62 years, female, white, stage:Stage II, alive, 848 days 2636.0
TCGA-CC-A5UE-01A 48 years, male, asian, stage:Stage IIIB, dead, 272 days 2606.6
TCGA-K7-A6G5-01A 66 years, male, white, stage:Stage I, alive, 512 days 2524.1
TCGA-DD-A39X-01A 78 years, female, white, stage:Stage I, dead, 1694 days 2505.2
TCGA-BC-A217-01A 75 years, female, white, stage:Stage II, dead, 1397 days 2486.8
TCGA-DD-AADN-01A 59 years, male, asian, stage:Stage I, alive, 898 days 2480.6
TCGA-DD-AADS-01A 63 years, male, asian, stage:Stage I, alive, 474 days 2467.0
TCGA-MI-A75I-01A 61 years, male, black or african american, stage:'--, alive, 630 days 2415.0
TCGA-3K-AAZ8-01A 65 years, male, black or african american, stage:Stage IIIB, alive, 396 days 2337.8
TCGA-DD-AADM-01A 58 years, male, asian, stage:Stage II, dead, 12 days 2323.7
TCGA-FV-A495-01A 51 years, female, white, stage:Stage II, alive, 1 days 2270.5
TCGA-DD-A73G-01A 73 years, female, white, stage:Stage I, alive, 3478 days 2208.1
TCGA-CC-A7II-01A 54 years, male, asian, stage:Stage IIIA, alive, 399 days 2105.9
TCGA-DD-A39Y-01A 67 years, male, asian, stage:Stage I, dead, 171 days 1974.6
TCGA-DD-AACI-01A 69 years, male, asian, stage:Stage II, alive, 1618 days 1945.3
TCGA-CC-A123-01A 24 years, female, asian, stage:Stage IIIA, alive, 219 days 1842.8
TCGA-CC-A7IJ-01A 56 years, male, asian, stage:Stage II, alive, 382 days 1823.3
TCGA-EP-A2KA-01A 52 years, female, white, stage:Stage IIIA, dead, 627 days 1749.3
TCGA-BC-A10W-01A 50 years, male, asian, stage:'--, dead, 91 days 1669.2
TCGA-ES-A2HT-01A 54 years, male, black or african american, stage:Stage I, dead, 438 days 1653.8
TCGA-DD-A39V-01A 77 years, male, white, stage:Stage II, dead, 643 days 1637.2
TCGA-FV-A4ZP-01A 78 years, male, white, stage:Stage IIIA, dead, 2486 days 1525.5
TCGA-ED-A5KG-01A 60 years, female, asian, stage:Stage II, alive, 854 days 1517.8
TCGA-FV-A4ZQ-01A 52 years, male, white, stage:Stage I, alive, 12 days 1446.7
TCGA-DD-AADO-01A 55 years, male, asian, stage:Stage I, alive, 453 days 1373.5
TCGA-BC-A69H-01A 64 years, male, white, stage:Stage II, alive, 444 days 1191.0
TCGA-G3-A25X-01A 73 years, male, asian, stage:Stage II, alive, 1779 days 1159.1
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

  Survival analysis data not available.
LIVER HEPATOCELLULAR CARCINOMA - Protein relative expression (CPTAC)
Number of samples 330
Samples
Sample ID Sample type nRPX
471 Tumor N/A
351 Tumor N/A
472 Normal N/A
231 Tumor N/A
352 Normal N/A
473 Tumor N/A
111 Normal N/A
232 Normal N/A
353 Tumor N/A
474 Normal N/A
112 Tumor N/A
354 Normal N/A
113 Tumor N/A
355 Tumor N/A
114 Normal N/A
356 Normal N/A
477 Tumor N/A
357 Tumor N/A
478 Normal N/A
358 Normal N/A
911 Tumor N/A
912 Normal N/A
913 Tumor N/A
914 Normal N/A
915 Tumor N/A
916 Normal N/A
917 Tumor N/A
918 Normal N/A
481 Tumor N/A
361 Tumor N/A
482 Normal N/A
362 Normal N/A
483 Tumor N/A
363 Tumor N/A
484 Normal N/A
364 Normal N/A
123 Tumor N/A
365 Tumor N/A
124 Normal N/A
366 Normal N/A
487 Tumor N/A
125 Tumor N/A
367 Tumor N/A
488 Normal N/A
126 Normal N/A
368 Normal N/A
127 Tumor N/A
128 Normal N/A
921 Tumor N/A
922 Normal N/A
923 Tumor N/A
924 Normal N/A
925 Tumor N/A
926 Normal N/A
491 Tumor N/A
492 Normal N/A
493 Tumor N/A
131 Tumor N/A
494 Normal N/A
132 Normal N/A
375 Tumor N/A
376 Normal N/A
497 Tumor N/A
135 Tumor N/A
498 Normal N/A
136 Normal N/A
257 Tumor N/A
137 Tumor N/A
258 Normal N/A
138 Normal N/A
813 Tumor N/A
814 Normal N/A
815 Tumor N/A
816 Normal N/A
937 Tumor N/A
817 Tumor N/A
938 Normal N/A
818 Normal N/A
261 Tumor N/A
141 Tumor N/A
262 Normal N/A
383 Tumor N/A
142 Normal N/A
384 Normal N/A
385 Tumor N/A
386 Normal N/A
145 Tumor N/A
387 Tumor N/A
146 Normal N/A
267 Tumor N/A
388 Normal N/A
147 Tumor N/A
268 Normal N/A
148 Normal N/A
943 Tumor N/A
823 Tumor N/A
944 Normal N/A
824 Normal N/A
1022 Normal N/A
1021 Tumor N/A
391 Tumor N/A
271 Tumor N/A
392 Normal N/A
272 Normal N/A
393 Tumor N/A
394 Normal N/A
395 Tumor N/A
396 Normal N/A
277 Tumor N/A
1016 Normal N/A
278 Normal N/A
1015 Tumor N/A
1014 Normal N/A
951 Tumor N/A
1013 Tumor N/A
952 Normal N/A
953 Tumor N/A
954 Normal N/A
713 Tumor N/A
955 Tumor N/A
714 Normal N/A
956 Normal N/A
715 Tumor N/A
957 Tumor N/A
716 Normal N/A
958 Normal N/A
1032 Normal N/A
1031 Tumor N/A
161 Tumor N/A
162 Normal N/A
283 Tumor N/A
284 Normal N/A
285 Tumor N/A
286 Normal N/A
1028 Normal N/A
1027 Tumor N/A
1026 Normal N/A
1025 Tumor N/A
721 Tumor N/A
963 Tumor N/A
722 Normal N/A
964 Normal N/A
723 Tumor N/A
965 Tumor N/A
724 Normal N/A
966 Normal N/A
967 Tumor N/A
968 Normal N/A
727 Tumor N/A
728 Normal N/A
1044 Normal N/A
1043 Tumor N/A
1042 Normal N/A
1041 Tumor N/A
171 Tumor N/A
172 Normal N/A
297 Tumor N/A
298 Normal N/A
851 Tumor N/A
852 Normal N/A
975 Tumor N/A
976 Normal N/A
977 Tumor N/A
615 Tumor N/A
857 Tumor N/A
978 Normal N/A
616 Normal N/A
737 Tumor N/A
858 Normal N/A
617 Tumor N/A
738 Normal N/A
618 Normal N/A
185 Tumor N/A
186 Normal N/A
187 Tumor N/A
188 Normal N/A
981 Tumor N/A
861 Tumor N/A
982 Normal N/A
741 Tumor N/A
862 Normal N/A
983 Tumor N/A
742 Normal N/A
863 Tumor N/A
984 Normal N/A
1046 Normal N/A
743 Tumor N/A
864 Normal N/A
1045 Tumor N/A
744 Normal N/A
865 Tumor N/A
745 Tumor N/A
866 Normal N/A
746 Normal N/A
867 Tumor N/A
868 Normal N/A
627 Tumor N/A
628 Normal N/A
191 Tumor N/A
192 Normal N/A
195 Tumor N/A
196 Normal N/A
873 Tumor N/A
874 Normal N/A
513 Tumor N/A
755 Tumor N/A
514 Normal N/A
635 Tumor N/A
756 Normal N/A
877 Tumor N/A
515 Tumor N/A
636 Normal N/A
878 Normal N/A
516 Normal N/A
517 Tumor N/A
518 Normal N/A
881 Tumor N/A
882 Normal N/A
641 Tumor N/A
883 Tumor N/A
642 Normal N/A
884 Normal N/A
523 Tumor N/A
524 Normal N/A
525 Tumor N/A
526 Normal N/A
647 Tumor N/A
527 Tumor N/A
648 Normal N/A
528 Normal N/A
411 Tumor N/A
412 Normal N/A
533 Tumor N/A
413 Tumor N/A
534 Normal N/A
414 Normal N/A
535 Tumor N/A
777 Tumor N/A
415 Tumor N/A
536 Normal N/A
778 Normal N/A
416 Normal N/A
537 Tumor N/A
538 Normal N/A
661 Tumor N/A
662 Normal N/A
421 Tumor N/A
663 Tumor N/A
422 Normal N/A
664 Normal N/A
785 Tumor N/A
423 Tumor N/A
665 Tumor N/A
786 Normal N/A
424 Normal N/A
545 Tumor N/A
666 Normal N/A
425 Tumor N/A
546 Normal N/A
426 Normal N/A
427 Tumor N/A
428 Normal N/A
671 Tumor N/A
672 Normal N/A
431 Tumor N/A
311 Tumor N/A
432 Normal N/A
553 Tumor N/A
312 Normal N/A
433 Tumor N/A
554 Normal N/A
313 Tumor N/A
434 Normal N/A
314 Normal N/A
435 Tumor N/A
436 Normal N/A
557 Tumor N/A
558 Normal N/A
563 Tumor N/A
443 Tumor N/A
564 Normal N/A
685 Tumor N/A
444 Normal N/A
686 Normal N/A
445 Tumor N/A
446 Normal N/A
567 Tumor N/A
447 Tumor N/A
568 Normal N/A
327 Tumor N/A
448 Normal N/A
328 Normal N/A
571 Tumor N/A
451 Tumor N/A
572 Normal N/A
331 Tumor N/A
452 Normal N/A
573 Tumor N/A
211 Tumor N/A
332 Normal N/A
574 Normal N/A
695 Tumor N/A
212 Normal N/A
696 Normal N/A
213 Tumor N/A
455 Tumor N/A
697 Tumor N/A
214 Normal N/A
456 Normal N/A
698 Normal N/A
217 Tumor N/A
218 Normal N/A
461 Tumor N/A
341 Tumor N/A
462 Normal N/A
221 Tumor N/A
342 Normal N/A
463 Tumor N/A
222 Normal N/A
343 Tumor N/A
464 Normal N/A
223 Tumor N/A
344 Normal N/A
465 Tumor N/A
224 Normal N/A
466 Normal N/A
467 Tumor N/A
468 Normal N/A
227 Tumor N/A
228 Normal N/A
Show allShow less
LIVER CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA066847

Antibody CAB033779
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Carcinoma, Hepatocellular, NOS
Cholangiocarcinoma

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org